Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD
- PMID: 22197855
- PMCID: PMC3208079
- DOI: 10.1097/MPG.0b013e318229da1a
Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD
Abstract
Objectives: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children in the United States. Although changes in diet are often recommended to improve NAFLD, little is known regarding the influence of diet on histologic features of the disease.
Subjects and methods: This was a prospective, cross-sectional registry-based study. Children (n = 149) enrolled in the multicenter nonalcoholic steatohepatitis (NASH) Clinical Research Network had demographic, anthropometric, clinical, laboratory, and histology data obtained, including the Block Brief Food Questionnaire. Subjects were grouped by presence or absence of steatohepatitis and grades of histologic features according to NASH Clinical Research Network criteria.
Results: No significant differences were found between children with steatosis compared with steatohepatitis for fraction of energy from fat, carbohydrates, and protein. Sugar-sweetened beverage consumption was low and did not correlate with histologic features, although uric acid, a surrogate marker for fructose intake, was significantly increased in those with definite NASH (P = 0.008). For all groups, vitamin E consumption was insufficient compared with the recommended daily allowance. Median consumption of vitamin E was lower in children with higher grade of steatosis (8.4 vs 6.1 vs 6.9 for grades I, II, and III, respectively, P = 0.05). Those consuming less vitamin C had increased ballooning degeneration (P = 0.05).
Conclusions: Children with NAFLD have a diet that is insufficient in vitamin E and this may contribute to the pathophysiology of NAFLD. In children with NAFLD, reported sugar-sweetened beverage consumption is low; however, uric acid, which may reflect total fructose consumption, was significantly associated with NASH and should be further evaluated.
Comment in
-
Uric acid as a surrogate for fructose intake is not supported.J Pediatr Gastroenterol Nutr. 2012 Mar;54(3):439; author reply 439-40. doi: 10.1097/MPG.0b013e3182467bd0. J Pediatr Gastroenterol Nutr. 2012. PMID: 22193179 No abstract available.
Similar articles
-
A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.J Acad Nutr Diet. 2014 Aug;114(8):1181-94. doi: 10.1016/j.jand.2014.01.009. Epub 2014 Mar 14. J Acad Nutr Diet. 2014. PMID: 24631112
-
Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.J Hepatol. 2017 May;66(5):1031-1036. doi: 10.1016/j.jhep.2016.12.025. Epub 2017 Feb 14. J Hepatol. 2017. PMID: 28214020
-
Uric acid as a surrogate for fructose intake is not supported.J Pediatr Gastroenterol Nutr. 2012 Mar;54(3):439; author reply 439-40. doi: 10.1097/MPG.0b013e3182467bd0. J Pediatr Gastroenterol Nutr. 2012. PMID: 22193179 No abstract available.
-
Fructose as a key player in the development of fatty liver disease.World J Gastroenterol. 2013 Feb 28;19(8):1166-72. doi: 10.3748/wjg.v19.i8.1166. World J Gastroenterol. 2013. PMID: 23482247 Free PMC article. Review.
-
[Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].Yakugaku Zasshi. 2019;139(9):1147-1153. doi: 10.1248/yakushi.19-00011-1. Yakugaku Zasshi. 2019. PMID: 31474630 Review. Japanese.
Cited by
-
The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.Nutrients. 2014 Dec 10;6(12):5679-703. doi: 10.3390/nu6125679. Nutrients. 2014. PMID: 25514388 Free PMC article. Review.
-
A Population Based Study of Liver Function amongst Adults with Hyperuricemia and Gout in the United States.Diseases. 2021 Sep 17;9(3):61. doi: 10.3390/diseases9030061. Diseases. 2021. PMID: 34562968 Free PMC article.
-
Accelerated Chondrogenic Differentiation of Human Perivascular Stem Cells with NELL-1.Tissue Eng Part A. 2016 Feb;22(3-4):272-85. doi: 10.1089/ten.TEA.2015.0250. Epub 2016 Jan 27. Tissue Eng Part A. 2016. PMID: 26700847 Free PMC article.
-
Vitamins and non-alcoholic fatty liver disease: A Molecular Insight⋆.Liver Res. 2021 Jun;5(2):62-71. doi: 10.1016/j.livres.2021.03.004. Epub 2021 Apr 4. Liver Res. 2021. PMID: 34221537 Free PMC article.
-
Serum Immunoglobulin A Levels Do Not Correlate With Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.J Pediatr Gastroenterol Nutr. 2018 Nov;67(5):631-634. doi: 10.1097/MPG.0000000000002104. J Pediatr Gastroenterol Nutr. 2018. PMID: 30363043 Free PMC article.
References
-
- Schwimmer J, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–1393. - PubMed
-
- Brunt E. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3–16. - PubMed
-
- Quiros-Tejeira RE, Rivera CA, Ziba TT, et al. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. J Pediatr Gastroenterol Nutr. 2007;44:228–36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1RR02501401/RR/NCRR NIH HHS/United States
- U01DK061713/DK/NIDDK NIH HHS/United States
- U01 DK061732/DK/NIDDK NIH HHS/United States
- U01DK061731/DK/NIDDK NIH HHS/United States
- U01DK061737/DK/NIDDK NIH HHS/United States
- U01 DK061731/DK/NIDDK NIH HHS/United States
- P30 DK079637/DK/NIDDK NIH HHS/United States
- M01 RR000188/RR/NCRR NIH HHS/United States
- U01DK061718/DK/NIDDK NIH HHS/United States
- RR02413101/RR/NCRR NIH HHS/United States
- U01DK061728/DK/NIDDK NIH HHS/United States
- U01 DK061730/DK/NIDDK NIH HHS/United States
- U01 DK061728/DK/NIDDK NIH HHS/United States
- M01 RR000065/RR/NCRR NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- U01 DK061734/DK/NIDDK NIH HHS/United States
- M01RR020359/RR/NCRR NIH HHS/United States
- M01RR000827/RR/NCRR NIH HHS/United States
- U01 DK061737/DK/NIDDK NIH HHS/United States
- U01 DK061713/DK/NIDDK NIH HHS/United States
- K23DK080953/DK/NIDDK NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- U01 DK061718/DK/NIDDK NIH HHS/United States
- M01RR000065/RR/NCRR NIH HHS/United States
- U01DK061732/DK/NIDDK NIH HHS/United States
- M01 RR000750/RR/NCRR NIH HHS/United States
- U01 DK061738/DK/NIDDK NIH HHS/United States
- UL1RR024989/RR/NCRR NIH HHS/United States
- U01DK061738/DK/NIDDK NIH HHS/United States
- UL1 RR025008/RR/NCRR NIH HHS/United States
- K23 DK080953/DK/NIDDK NIH HHS/United States
- M01 RR000827/RR/NCRR NIH HHS/United States
- M01RR00188/RR/NCRR NIH HHS/United States
- U01DK061734/DK/NIDDK NIH HHS/United States
- U01DK061730/DK/NIDDK NIH HHS/United States
- M01 RR020359/RR/NCRR NIH HHS/United States
- M01RR000750/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical